01.04.23 -- How Digital Devices Enable Safety Monitoring At Home
Welcome to the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. Update your topic preferences to receive additional Clinical Leader newsletters on:
In this short video, Ed Miseta, chief editor of Clinical Leader, and Terttu Haring, head of the clinical innovation office at Sanofi, discuss the use of devices that will enable safe monitoring from a patient’s home.
Article | By Joyce Smith, MRN - Medical Research Network
Patient- and family-centric trial designs are vital to promoting recruitment, retention, and quality care among challenging patient groups, including pediatric, geriatric, low-mobility, and neurological patients.
From The Editor | By Ed Miseta, chief editor, Clinical Leader
South Rampart Pharma aims to deliver a new, affordable treatment for pain that will avoid the issues with currently marketed products. Opioids are highly addictive, patients taking excessive amounts of acetaminophen can develop liver toxicity, and NSAID over-exposure risks kidney toxicity, gastrointestinal (GI) bleeding, and worsening of high blood pressure in patients with hypertension.
When it comes to clinical trials in particular, myths are common. From the view that clinical trials are dangerous, to the idea that participants don’t know the details of a trial or the treatments they might take, false notions persist. Unpack these myths in this blog.
Discover why thoughtful up-front planning and a clear understanding of the obstacles patients face are crucial when understanding the components of an ALS trial.
Learn about the keys to successful clinical trials, the challenges that plague trial finances from budgeting through payment execution, and how financial automation benefits all clinical trial stakeholders.
DXA remains the gold standard test for bone mineral density assessments. Hear more about how DXA scans work, who should get one, and whether their use will become more widespread in clinical trials, akin to cardiac safety testing.
Is the clinical trial setting the best environment to ensure a patient’s safety? Dr. Jamie P. Dwyer discusses how nephrology clinical trials identify future patient risk factors for medication and treatment in the real-world setting.
An eClinical supply chain management platform can help sponsors and research sites reduce risk, increase patient retention, and have an overall more successful clinical trial.
Now is the time to step forward and realize the benefits of digital transformation. Learn how you can innovate and embrace the future of clinical trials today.
This newsletter is being sent to {{lead.Email Address}}. If the topics covered in it are no longer of interest to you, you can change your topic preferences on your profile page. To cancel your subscription to all Clinical Leader newsletters, please unsubscribe.
This website uses cookies to ensure you get the best experience on our website. Learn more